tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

INBX Stock Latest News

Inhibrx downgraded to Hold from Buy at Jefferies
The FlyInhibrx downgraded to Hold from Buy at Jefferies
2M ago
SNY
INBX
Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results
PremiumPress Releases
Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results
2M ago
INBX
Inhibrx reports Q4 EPS ($1.73), consensus ($1.04)
PremiumThe Fly
Inhibrx reports Q4 EPS ($1.73), consensus ($1.04)
2M ago
INBX
Inhibrx Announces Execution of Merger Agreement
PremiumMarket News
Inhibrx Announces Execution of Merger Agreement
3M ago
8K
INBX
Inhibrx Announces Merger and Spin-Off Agreements with Aventis
PremiumMarket News
Inhibrx Announces Merger and Spin-Off Agreements with Aventis
3M ago
8K
INBX
Inhibrx downgraded to Market Perform from Outperform at LifeSci Capital
PremiumThe FlyInhibrx downgraded to Market Perform from Outperform at LifeSci Capital
3M ago
INBX
M&A News: Sanofi Expands into Rare Diseases with Inhibrx Deal
PremiumGlobal Markets
M&A News: Sanofi Expands into Rare Diseases with Inhibrx Deal
3M ago
INBX
Inhibrx to sell INBRX-101 to Sanofi in $2.2B transaction
PremiumThe Fly
Inhibrx to sell INBRX-101 to Sanofi in $2.2B transaction
3M ago
SNY
INBX
Inhibrx downgraded to Market Perform from Outperform at JMP Securities
PremiumThe Fly
Inhibrx downgraded to Market Perform from Outperform at JMP Securities
3M ago
INBX
Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B
PremiumPress Releases
Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B
3M ago
SNY
INBX
Inhibrx Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
PremiumPress Releases
Inhibrx Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
6M ago
INBX
Inhibrx reports Q3 EPS ($1.10), consensus ($1.01)
PremiumThe Fly
Inhibrx reports Q3 EPS ($1.10), consensus ($1.01)
6M ago
INBX
Inhibrx reports preliminary Phase 1 efficacy and safety data in Ewing sarcoma
PremiumThe FlyInhibrx reports preliminary Phase 1 efficacy and safety data in Ewing sarcoma
6M ago
INBX
Inhibrx announces Chiesi Farmaceutici declined option for rights on INBRX-101
PremiumThe Fly
Inhibrx announces Chiesi Farmaceutici declined option for rights on INBRX-101
7M ago
INBX
Inhibrx sells 3.62M shares at $19.35 in private placement
PremiumThe Fly
Inhibrx sells 3.62M shares at $19.35 in private placement
8M ago
INBX
Inhibrx price target lowered to $27 from $35 at JMP Securities
PremiumThe Fly
Inhibrx price target lowered to $27 from $35 at JMP Securities
8M ago
INBX
Inhibrx Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
PremiumPress Releases
Inhibrx Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
9M ago
INBX
Inhibrx reports Q2 EPS ($1.08), consensus ($1.03)
PremiumThe Fly
Inhibrx reports Q2 EPS ($1.08), consensus ($1.03)
9M ago
INBX
INBX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
INBX Upcoming Earnings Report: What to Expect?
9M ago
INBX
Inhibrx Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
PremiumPress ReleasesInhibrx Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
12M ago
INBX
Inhibrx Inc (INBX) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Inhibrx Inc (INBX) Q1 Earnings Cheat Sheet
12M ago
INBX
Inhibrx begins registration-enabling trial of AATD candidate, resumes Phase 1
PremiumThe Fly
Inhibrx begins registration-enabling trial of AATD candidate, resumes Phase 1
1y ago
INBX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >